Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $5.1050 (3.34%) ($4.9300 - $5.2300) on Tue. May. 19, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 9.91% (three month average) | RSI | 69 | Latest Price | $5.1050(3.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.2% a day on average for past five trading days. | Weekly Trend | BCRX advances 14.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) IBB(9%) IWC(9%) IWM(9%) XHB(9%) IFRA(8%) | Factors Impacting BCRX price | BCRX will decline at least -4.955% in a week (0% probabilities). IGOV(-6%) TLT(-3%) VIXM(-2%) UUP(-2%) INDA(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.955% (StdDev 9.91%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $5.06(0.89%) | 10 Day Moving Average | $4.89(4.4%) | 20 Day Moving Average | $4.28(19.28%) | To recent high | -7.4% | To recent low | 0.6% | Market Cap | $901m | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |